fda warning letter semaglutide october 2025 glp-1 enforcement news issued 25 letters to telehealth companies for false Prescription Drug Freight Fraud Report, – Compounded GLP-1s: Why doctors worry

North America is one of the markets showing steady growth in oral GLP-1 agonists owing to the high prevalence of the disease and early adoption of newer drugs

Copper Peptides have been extensively researched for effectiveness, and now most high-end cosmetic companies employ them in their pricy products

Kellogs Safe Fat Reducer were common in the late 1800s, with dubious results

For someone taking semaglutide, whose digestive system is already working more slowly, these foods can sit in the stomach for hours, leading to persistent discomfort

law, compounding is generally appropriate only when there is a legitimate clinical need that cannot be met by FDA-approved products